FcgRIIa-131R and FcgRIIIa-158 V allotypes were associated with significantly better overall in survival of colorectal carcinoma patients receiving either passively administered monoclonal antibodies or antibodies induced by carcinoembryonic antigen (CEA) vaccination [13]. The gene discussed is CEACAM5; the disease is colorectal carcinoma.